Abstract
Off-target genome editing in the liver can be reduced by using lipid nanoparticles to deliver oligonucleotides that disrupt the secondary structure of single-guide RNAs as well as short interfering RNAs targeting Cas9 mRNA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have